WCO classification path
- Chapter30Pharmaceutical products
- Heading3004Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (iincluding those in the form of transdermal administration systems) or in forms or packings for retail sale
- Subheading300432Containing corticosteroid hormones, their derivatives or structural analogues
- National30043200Containing corticosteroid hormones, their derivatives or structural analogues
30043200
What is the Korea import tariff for HS 30043200 (Containing corticosteroid hormones, their derivati)?
Quick answer: Korea MFN rate for HS 30043200 is 8. 1 import permit / restriction(s) apply. 30 FTA preferential rate(s) available.
"Containing corticosteroid hormones, their derivatives or structural analogues"
HS code 3004320000 (Chapter 30 "Pharmaceutical products"; Heading 3004 "Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (iincluding those in the form of transdermal administration systems) or in forms or packings for retail sale"; Subheading 300432 "Containing corticosteroid hormones, their derivatives or structural analogues") under the Korea tariff schedule classifies "Containing corticosteroid hormones, their derivatives or structural analogues". Korea customs apply MFN rate of 8, WTO bound rate 0. Statutory unit of measure: KG. This commodity is subject to 1 import regulation or restriction; see compliance section below. 30 free trade agreement preferential rates are available for this code.
Tariff Schedule
| Classification | Rate |
|---|---|
MFN 税率 MFN rate | 8 |
WTO 约束税率 WTO bound rate | 0 |
Duty + VAT + surcharges, line by line — just enter your value
FTA Preferential Rates
30 agreements available · certificate of origin required
| Agreement | Rate |
|---|---|
| AKFTA (ASEAN-Korea) | 0% |
| KAFTA (Korea-Australia) | 0% |
| CKFTA (Canada-Korea) / CPTPP | 0% |
| Korea-Central America (Costa Rica) | 0% |
| Korea-Central America (Honduras) | 0% |
| Korea-Central America (Nicaragua) | 0% |
| Korea-Central America (Panama) | 0% |
| Korea-Central America (El Salvador) | 0% |
| Korea-Chile | 0% |
| Korea-China | 0% |
| Korea-Colombia | 0% |
| Korea-EFTA | 0% |
| Korea-EU | 0% |
| Korea-UK | 0% |
| Korea-Indonesia (CEPA) | 0% |
| Korea-Israel | 0% |
| Korea-India (CEPA) | 0% |
| Korea-Cambodia | 0% |
| Korea-New Zealand | 0% |
| Korea-Peru | 0% |
| Korea-Philippines | 0% |
| RCEP (ASEAN) | 0% |
| RCEP (Australia) | 0% |
| RCEP (China) | 0% |
| RCEP (New Zealand) | 0% |
| Korea-Turkey | 0% |
| KORUS (Korea-US) | 0% |
| Korea-Vietnam | 0% |
| RCEP | 0% |
| RCEP (Japan) | 4% |
Compliance & Controls
1 import regulation, restriction, or permit requirement
약사법
표준통관예정보고서(의약품등)
Global Benchmark
HS-6 prefix 3004.32 across other jurisdictions